PTD10

N/A

Report date: 2023/05/29 15:32:28
NME

Base Information

Drug NamePTD10
Drug Alias NamePTD10PTD-10
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK degraders
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStony Brook University
China Registration ClassN/A

Develop Information

Active CompaniesStony Brook University
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A